Letter to the Editor Regarding Blood Group AB is Associated with Poor Outcomes in Infants with Necrotising Enterocolitis

Author(s):  
Ian Munro Rogers
2017 ◽  
Vol 32 (8) ◽  
pp. 2621-2622
Author(s):  
Raju Vaishya ◽  
Hena Butta ◽  
Raman Sardana ◽  
Abhishek Vaish ◽  
Vipul Vijay ◽  
...  

2021 ◽  
Vol 10 (22) ◽  
pp. 5431
Author(s):  
Óscar Gorgojo-Galindo ◽  
Marta Martín-Fernández ◽  
María Jesús Peñarrubia-Ponce ◽  
Francisco Javier Álvarez ◽  
Christian Ortega-Loubon ◽  
...  

Pneumonia is the main cause of hospital admission in COVID-19 patients. We aimed to perform an extensive characterization of clinical, laboratory, and cytokine profiles in order to identify poor outcomes in COVID-19 patients. Methods: A prospective and consecutive study involving 108 COVID-19 patients was conducted between March and April 2020 at Hospital Clínico Universitario de Valladolid (Spain). Plasma samples from each patient were collected after emergency room admission. Forty-five serum cytokines were measured in duplicate, and clinical data were analyzed using SPPS version 25.0. Results: A multivariate predictive model showed high hepatocyte growth factor (HGF) plasma levels as the only cytokine related to intubation or death risk at hospital admission (OR = 7.38, 95%CI—(1.28–42.4), p = 0.025). There were no comorbidities included in the model except for the ABO blood group, in which the O blood group was associated with a 14-fold lower risk of a poor outcome. Other clinical variables were also included in the predictive model. The predictive model was internally validated by the receiver operating characteristic (ROC) curve with an area under the curve (AUC) of 0.94, a sensitivity of 91.7% and a specificity of 95%. The use of a bootstrapping method confirmed these results. Conclusions: A simple, robust, and quick predictive model, based on the ABO blood group, four common laboratory values, and one specific cytokine (HGF), could be used in order to predict poor outcomes in COVID-19 patients.


PEDIATRICS ◽  
1970 ◽  
Vol 45 (2) ◽  
pp. 343-344
Author(s):  
Robert L. Replogle

The letter from Doctors Hoffman and Canby touches on one area about which there is probably widespread controversy, namely the type of fluid to be used for the immediate restoration of blood loss. I would strongly disagree with their recommendation that universal donor low titer blood be infused rather than wait 30 minutes for emergency cross-matched blood to be made available. Although the morbidity associated with incompatibility is low following infusion of low titer blood, the presence of residual transfused antibody to the patient's hereditary blood group may lead to a hemolytic transfusion reaction when subsequent transfusions of cross-matched blood are given.


2017 ◽  
Vol 32 (8) ◽  
pp. 2622-2624
Author(s):  
Michael M. Kheir ◽  
Timothy L. Tan ◽  
Carlos Higuera ◽  
Jaiben George ◽  
Craig Della Valle ◽  
...  

Author(s):  
Raquel Dos Santos Martins ◽  
Elisabeth M.W. Kooi ◽  
Willemien S. Kalteren ◽  
Klaas Poelstra ◽  
Arend F. Bos ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document